BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,316.00
      -0.28%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.57
      0.17%
      Bitcoin
      93,833.47
      2.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Verve Therapeutics Inc (VERV)

      7. Verve Therapeutics Inc (VERV) Financials

      Verve Therapeutics Inc

      Verve Therapeutics Inc (VERV)

      Verbund Ag
      Verbund Ag
      Verbund Ag
      Verbund Ag
      5.31
      0.02
      (0.38%)
      Closed November 26 4:00PM
      Delayed by 15 minutes
      5.31
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Verve Therapeutics Inc Financial Summary

      The current VERV market cap is 449.56M. The company's latest EPS is USD -2.3631 and P/E is -2.25.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.09M3.12M5.14M5.7M6.69M
      Operating Income -58.58M-52.33M-53.95M-56.84M-58.84M
      Net Income -53.98M-45.76M-48.35M-48.74M-49.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0001.94M11.76M
      Operating Income -13.64M-40.63M-87.07M-165.69M-223.12M
      Net Income -19.3M-45.7M-120.31M-157.39M-200.07M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 589.13M612.41M752.69M732.36M700.91M
      Total Liabilities 123.91M152.04M153.19M149.29M154.82M
      Total Equity 465.22M460.37M599.5M583.07M546.09M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 21.65M78.41M384.12M679.22M752.69M
      Total Liabilities 15.72M17.16M26.77M128.29M153.19M
      Total Equity -19.55M-63.91M357.35M550.93M599.5M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -97.06M-108.87M-149.55M-43.08M-77.24M
      Investing 48.42M36.58M27.69M-41.63M-11.48M
      Financing 3.27M35.19M212.58M22.73M24.03M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -7.44M-35.27M-77.88M-122.33M-149.55M
      Investing -12.76M-51.13M-239.1M-155.96M27.69M
      Financing 17.95M92.63M377.09M328.96M212.58M

      Stats and Ratios

      Market Cap 449.56M
      Price to Earnings Ratio -2.25
      Price to Sales Ratio 38.23
      Price to Cash Ratio 2.18
      Price to Book Ratio 0.75
      Dividend Yield -

      Share Statistics

      Shares Outstanding 84.66M
      Average Volume (1 week) 1.47M
      Average Volume (1 Month) 1.67M
      52 Week Change -57.25%
      52 Week High 19.34
      52 Week Low 4.305
      Spread (Intraday) 0.74 (13.24%)

      Company Info

      Company Name Verve Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.vervetx.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      VERV
      Verve Therapeutics
      Delayed Upgrade Clock